Blood Draw at Stanford Cancer Center

Dr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University. Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.

The Stanford Cancer Immunotherapy Program is dedicated to harnessing the immune system to combat cancer through innovative treatments and delivery mechanisms. The program brings together physician-scientists who are advancing patient-specific vaccines and cell-based therapies to stimulate robust immune responses against various cancer types. With a history of groundbreaking developments, Stanford has pioneered the use of monoclonal antibodies in cancer therapy and continues to explore new therapeutic agents, including cytokines and combination therapies. Their research efforts focus on creating effective cancer vaccines and cellular immunotherapies to enhance the body's natural defenses against cancer. Generated from the website